Strides Pharma Science Limited — Updates, 24-12-2025: General Updates
24-12-2025 | 06:28 pm
24-12-2025 | 06:28 pm
Strides Pharma Inc. (US subsidiary) saw US-FDA issue a Form 483 with four procedural observations following a routine inspection. The company anticipates no impact on commercial product supply, planning a comprehensive response.
No comments yet. Be the first to comment!
